GlobeNewswire - Prospectus, Announcement Of Prospectus Contains the last 20 releases uuid:69086870-5c99-4b7e-a559-1347a337c26d;id=6031 2021-02-04T22:16:25Z newsdesk@globenewswire.com (NewsDesk) http://www.10gbhost.com/LegacyRss?Length=4 newsdesk@globenewswire.com http://www.10gbhost.com/news-release/2021/02/04/2170379/0/en/CORRECTION-Itamar-Medical-Announces-Proposed-Offering-of-American-Depositary-Shares.html CORRECTION – Itamar Medical Announces Proposed Offering of American Depositary Shares 2021-02-04T22:16:25Z 2021-02-05T07:57:26Z CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- In a release issued under the same headline on Thursday, February 4th by Itamar Medical Ltd. (Nasdaq: ITMR) (TASE: ITMR), please note that the contact information was incorrect. The corrected release follows:

]]>
2170379 en GlobeNewswire Inc. Itamar Medical Ltd. Thu, 04 Feb 2021 22:16 GMT Changes in company's own shares Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/02/04/2170304/0/en/Itamar-Medical-Announces-Proposed-Offering-of-American-Depositary-Shares.html Itamar Medical Announces Proposed Offering of American Depositary Shares 2021-02-04T21:01:00Z 2021-02-05T07:57:26Z CAESAREA, Israel, Feb. 04, 2021 (GLOBE NEWSWIRE) -- Itamar Medical Ltd. (“Itamar Medical” or the “Company”) (Nasdaq: ITMR) (TASE: ITMR), a medical technology company focused on the development and commercialization of non-invasive medical devices to aid in the diagnosis of respiratory sleep disorders, today announced the commencement of a proposed public offering of American Depositary Shares (“ADSs”) of the Company. Each ADS represents 30 ordinary shares of the Company. The ADSs to be sold in the offering will be offered by the Company and one of its shareholders, Viola Growth 2 A.V. Limited Partnership (the “Selling Shareholder”). The Company and the Selling Shareholder intend to grant to the underwriters a 30-day option to purchase up to an additional 15% of the ADSs being offered on the same terms and conditions. The offering is subject to market conditions, and there can be no assurance as to whether or when the offering may be completed or as to the actual size or terms of the offering.

]]>
2170304 en GlobeNewswire Inc. Itamar Medical Ltd. Thu, 04 Feb 2021 21:01 GMT Changes in company's own shares Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/02/03/2168761/0/da/Offentligg%C3%B8relse-af-prospekt-for-Investeringsforeningen-Danske-Invest-og-Investeringsforeningen-Danske-Invest-Select.html Offentligg?relse af prospekt for Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select 2021-02-03T08:02:33Z 2021-02-05T07:57:26Z Vi skal herved oplyse, at der er foretaget ?ndringer i prospekterne for Investeringsforeningen Danske Invest og Investeringsforeningen Danske Invest Select.

]]>
2168761 da GlobeNewswire Inc. Danske Invest Wed, 03 Feb 2021 08:02 GMT Prospectus/Announcement of Prospectus European Regulatory News
http://www.10gbhost.com/news-release/2021/02/02/2168613/0/en/Outlook-Therapeutics-Announces-Closing-of-35-0-Million-Bought-Deal.html Outlook Therapeutics Announces Closing of $35.0 Million Bought Deal 2021-02-02T21:05:00Z 2021-02-05T07:57:26Z MONMOUTH JUNCTION, N.J., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Outlook Therapeutics, Inc. (Nasdaq: OTLK) (“Outlook Therapeutics”), a?late clinical-stage?biopharmaceutical company?working to develop the first FDA-approved ophthalmic formulation of bevacizumab-vikg for use in retinal indications, today announced the closing of its previously announced underwritten public offering of 35,000,000 shares of common stock of the Company at a price to the public of $1.00 per share. As previously announced, the company has granted the underwriter a 30-day option to purchase up to 5,250,000 additional shares of its common stock at the public offering price, less underwriting discounts and commissions.

]]>
2168613 en GlobeNewswire Inc. Outlook Therapeutics, Inc. Tue, 02 Feb 2021 21:05 GMT Changes in company's own shares Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/02/02/2168618/0/en/Neuronetics-Announces-Closing-of-Public-Offering-and-Exercise-in-Full-of-the-Underwriters-Option-to-Purchase-Additional-Shares.html Neuronetics Announces Closing of Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares 2021-02-02T21:05:00Z 2021-02-05T07:57:26Z MALVERN, Pa., Feb. 02, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced the closing of an underwritten public offering of 5,566,000 shares of its common stock, including the exercise in full by the underwriters of their option to purchase up to an additional 726,000 shares of common stock, at a public offering price of $15.50 per share. Net proceeds from the offering were approximately $80.6 million, after deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company.

]]>
2168618 en GlobeNewswire Inc. Neuronetics Tue, 02 Feb 2021 21:06 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/02/01/2166990/0/da/Nyt-referenceindeks-i-SKAGEN-Avkastning.html Nyt referenceindeks i SKAGEN Avkastning 2021-02-01T08:00:00Z 2021-02-05T07:57:26Z SKAGEN Avkastning skifter referenceindeks d. 1. februar 2021. ?rsagen til ?ndringen er, at b?rsen i Oslo, som hidtil har leveret indekset, med udgangen af januar 2021 ikke leverer dette l?ngere.

]]>
2166990 da GlobeNewswire Inc. SKAGEN Fondene AS Mon, 01 Feb 2021 08:00 GMT Prospectus/Announcement of Prospectus European Regulatory News
http://www.10gbhost.com/news-release/2021/01/29/2166375/0/en/Neuronetics-Announces-Pricing-of-75-Million-Public-Offering-of-Common-Stock.html Neuronetics Announces Pricing of $75 Million Public Offering of Common Stock 2021-01-29T03:30:12Z 2021-02-05T07:57:26Z MALVERN, Pa., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Neuronetics, Inc. (NASDAQ: STIM) (the “Company”), a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced that it has priced the previously announced underwritten public offering of 4,840,000 shares of its common stock, at a public offering price of $15.50 per share. The Company has granted the underwriters a 30-day option to purchase up to an additional 726,000 shares of its common stock. The gross proceeds to the Company from this offering are expected to be approximately $75.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by the Company. The offering is expected to close on or about February 2, 2021, subject to satisfaction of customary closing conditions.

]]>
2166375 en GlobeNewswire Inc. Neuronetics Fri, 29 Jan 2021 03:30 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/28/2166022/0/en/VSiN-The-Sports-Betting-Network-to-Deliver-the-Deepest-Big-Game-Coverage-Ever-Available-to-Sports-Betting-Fans.html VSiN, The Sports Betting Network, to Deliver the Deepest Big Game Coverage Ever Available to Sports Betting Fans 2021-01-28T15:00:00Z 2021-02-05T07:57:26Z Network’s Offering Represents the Most In-Depth Coverage of the Expanding Betting Markets for What is Expected to Be the Most Bet U.S. Sporting Event in History]]> 2166022 en GlobeNewswire Inc. VSiN Thu, 28 Jan 2021 15:00 GMT Prospectus/Announcement of Prospectus VSiN Super Bowl sports betting http://www.10gbhost.com/news-release/2021/01/28/2165449/0/en/Seer-Announces-Pricing-of-Upsized-Public-Offering-of-Common-Stock.html Seer Announces Pricing of Upsized Public Offering of Common Stock 2021-01-28T03:51:15Z 2021-02-05T07:57:26Z REDWOOD CITY, Calif., Jan. 27, 2021 (GLOBE NEWSWIRE) -- Seer, Inc., a life sciences company commercializing a disruptive new platform for proteomics, today announced the pricing of an underwritten public offering of 3,750,000 shares of Class A common stock (1,650,000 of which are being offered for sale by Seer and 2,100,000 are being offered for sale by selling stockholders of Seer) at a public offering price of $67.00 per share. In addition, the selling stockholders of Seer have granted the underwriters a 30-day option to purchase up to 562,500 additional shares of Class A common stock at the public offering price, less underwriting discounts and commissions. The offering is expected to close on or about February 1, 2021, subject to satisfaction of customary closing conditions. Seer will not receive any proceeds from the sale of shares in the offering by selling stockholders.

]]>
2165449 en GlobeNewswire Inc. Seer, Inc. Thu, 28 Jan 2021 03:51 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/25/2163366/0/en/Sunrun-Inc-Announces-Proposed-Private-Offering-of-350-Million-of-Convertible-Senior-Notes.html Sunrun Inc. Announces Proposed Private Offering of $350 Million of Convertible Senior Notes 2021-01-25T12:00:00Z 2021-02-05T07:57:26Z SAN FRANCISCO, Jan. 25, 2021 (GLOBE NEWSWIRE) -- Sunrun Inc. (Nasdaq: RUN) (“Sunrun”) today announced that it intends to offer, subject to market conditions and other factors,?$350 million?aggregate principal amount of convertible senior notes due 2026 (the “notes”) in a private placement to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended (the “Securities Act”). Sunrun also intends to grant the initial purchasers of the notes the option to purchase up to an additional $50 million aggregate principal amount of the notes within a 13-day period beginning on, and including, the date on which the notes are first issued.

]]>
2163366 en GlobeNewswire Inc. Sunrun Inc. Mon, 25 Jan 2021 12:00 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/22/2162966/0/en/Lithium-Americas-Closes-US-400-Million-Underwritten-Public-Offering.html Lithium Americas Closes US$400 Million Underwritten Public Offering 2021-01-22T15:42:38Z 2021-02-05T07:57:26Z VANCOUVER, British Columbia, Jan. 22, 2021 (GLOBE NEWSWIRE) -- Lithium Americas Corp. (TSX: LAC) (NYSE: LAC) ("Lithium Americas" or the "Company") announced today the closing of its previously announced underwritten public offering (the “Offering”) of shares of its common stock (the “Common Shares”). The Company issued 18,181,818 Common Shares, including 2,272,727 Common Shares following the exercise in full by the underwriters of their over-allotment option. The shares were issued at a price of US$22.00 per Common Share for gross proceeds to the Company of approximately US$400 million.

]]>
2162966 en GlobeNewswire Inc. Lithium Americas Fri, 22 Jan 2021 15:42 GMT Financing Agreements Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/22/2162866/0/en/21Vianet-Announces-Pricing-of-Offering-of-US-525-million-Convertible-Senior-Notes.html 21Vianet Announces Pricing of Offering of US$525 million Convertible Senior Notes 2021-01-22T13:30:00Z 2021-02-05T07:57:26Z BEIJING, Jan. 22, 2021 (GLOBE NEWSWIRE) -- 21Vianet Group, Inc. (Nasdaq: VNET) (“21Vianet” or the “Company”), a leading carrier-neutral and cloud-neutral data center services provider in China, today announced the pricing of its previously announced offering (the “Notes Offering”) of US$525 million in aggregate principal amount of convertible senior notes due 2026 (the “Notes”). The Company granted the initial purchasers in the Notes Offering a 13-day option to purchase up to an additional US$75 million in aggregate principal amount of the Notes. The Company plans to use the net proceeds from the Notes Offering for expanding data center infrastructure, repaying the Company’s outstanding senior notes due 2021 and other general corporate purposes.

]]>
2162866 en GlobeNewswire Inc. 21Vianet Group, Inc. Fri, 22 Jan 2021 13:30 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/21/2162500/0/en/Global-Ship-Lease-Announces-Commencement-of-Public-Offering-of-Class-A-Common-Shares.html Global Ship Lease Announces Commencement of Public Offering of Class A Common Shares 2021-01-21T21:01:00Z 2021-02-05T07:57:26Z LONDON, Jan. 21, 2021 (GLOBE NEWSWIRE) -- Global Ship Lease, Inc. (NYSE: GSL) (the “Company”) announced today that it intends to commence an underwritten public offering (the “Offering”) of its Class A common shares, par value $0.01 per share (the “Common Shares”). The net proceeds of the Offering are expected to be used for funding the expansion of the Company’s fleet, general corporate purposes, and working capital.

]]>
2162500 en GlobeNewswire Inc. Global Ship Lease Inc. Thu, 21 Jan 2021 21:01 GMT Financing Agreements Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/21/2162382/0/da/Opdateret-prospekt-for-Investeringsforeningen-Sparinvest.html Opdateret prospekt for Investeringsforeningen Sparinvest 2021-01-21T16:15:00Z 2021-02-05T07:57:26Z ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg offentligg?r opdateret prospekt for Investeringsforeningen Sparinvest med tilh?rende afdelinger.

]]>
2162382 da GlobeNewswire Inc. Investeringsforeningen Sparinvest Thu, 21 Jan 2021 16:16 GMT Prospectus/Announcement of Prospectus European Regulatory News
http://www.10gbhost.com/news-release/2021/01/21/2161888/0/da/Opdateret-prospekt-for-V%C3%A6rdipapirfonden-Sparindex.html Opdateret prospekt for V?rdipapirfonden Sparindex 2021-01-21T08:57:00Z 2021-02-05T07:57:26Z ID-SOpdateret prospekt for V?rdipapirfonden Sparindexparinvest, Filial af Sparinvest S.A., Luxembourg offentligg?r opdateret prospekt for V?rdipapirfonden Sparindex med tilh?rende afdelinger.

]]>
2161888 da GlobeNewswire Inc. V?rdipapirfonden Sparindex Thu, 21 Jan 2021 08:57 GMT Prospectus/Announcement of Prospectus European Regulatory News
http://www.10gbhost.com/news-release/2021/01/21/2161829/0/en/CareDx-Announces-Pricing-of-Public-Offering-of-Common-Stock.html CareDx Announces Pricing of Public Offering of Common Stock 2021-01-21T03:56:40Z 2021-02-05T07:57:26Z SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CareDx, Inc.?(Nasdaq: CDNA), a leading precision medicine company focused on the discovery, development and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the pricing of an underwritten public offering of 1,923,077 shares of its common stock at a public offering price of $91.00 per share. The gross proceeds to CareDx from this offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $175,000,007. In addition, CareDx has granted the underwriters a 30 day option to purchase up to 288,461 additional shares of its common stock offered in the public offering on the same terms and conditions. The offering is expected to close on or about January 25, 2021, subject to the satisfaction of customary closing conditions.

]]>
2161829 en GlobeNewswire Inc. CareDx, Inc. Thu, 21 Jan 2021 03:57 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/21/2161828/0/en/Editas-Medicine-Announces-Pricing-of-Offering-of-Common-Stock.html Editas Medicine Announces Pricing of Offering of Common Stock 2021-01-21T03:30:00Z 2021-02-05T07:57:26Z CAMBRIDGE, Mass., Jan. 20, 2021 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading gene editing company, today announced the pricing of an underwritten offering of 3,500,000 shares of its common stock at a public offering price of $66.00 per share, before deducting underwriter discounts and commissions and estimated offering expenses. Gross proceeds from the offering are expected to be approximately $231.0 million. Editas Medicine has granted the underwriters a 30-day option to purchase up to an additional 525,000 shares of common stock on the same terms and conditions. All of the shares in the offering are to be sold by Editas Medicine. The offering is expected to close on or about January 25, 2021, subject to customary closing conditions.

]]>
2161828 en GlobeNewswire Inc. Editas Medicine, Inc. Thu, 21 Jan 2021 03:30 GMT Stock Market News Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/21/2161824/0/en/CytomX-Therapeutics-Announces-Pricing-of-100-Million-Public-Offering-of-Common-Stock.html CytomX Therapeutics Announces Pricing of $100 Million Public Offering of Common Stock 2021-01-21T02:50:00Z 2021-02-05T07:57:26Z SOUTH SAN FRANCISCO, Calif., Jan. 20, 2021 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc.?(Nasdaq:CTMX), a clinical-stage, oncology-focused biopharmaceutical company with a vision of transforming lives with safer, more effective therapies, today announced the pricing of an underwritten public offering of 14,285,714 shares of its common stock at a price to the public of?$7.00?per share, for gross proceeds of?$100 million, before deducting underwriting discounts and commissions and estimated offering expenses payable by CytomX. All shares are being offered by CytomX. In addition, CytomX has granted the underwriters a 30-day option to purchase up to an additional 2,142,857 shares of its common stock at the public offering price, on the same terms and conditions.

]]>
2161824 en GlobeNewswire Inc. CytomX Therapeutics Inc. Thu, 21 Jan 2021 02:50 GMT Initial Public Offerings Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/19/2161037/0/en/Corsair-Gaming-Inc-Launches-Public-Offering-by-Selling-Stockholders.html Corsair Gaming, Inc. Launches Public Offering by Selling Stockholders 2021-01-19T21:19:15Z 2021-02-05T07:57:26Z FREMONT, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Corsair Gaming, Inc. (NASDAQ:CRSR) (“Corsair”), a leading global provider and innovator of high-performance gear for gamers and content creators, announced today the launch of a public offering of 7,500,000 shares of common stock to be sold by certain selling stockholders of Corsair. In addition, certain of the selling stockholders are expected to grant the underwriters a 30-day option to purchase up to an additional 1,125,000 shares of common stock. The selling stockholders will receive all of the net proceeds from the offering and Corsair will not receive any proceeds. The offering is subject to market conditions, and there can be no assurance as to whether, or when, the offering may be completed or as to the actual size or terms of the offering.

]]>
2161037 en GlobeNewswire Inc. Corsair Gaming, Inc. Tue, 19 Jan 2021 21:19 GMT Changes in company's own shares Prospectus/Announcement of Prospectus
http://www.10gbhost.com/news-release/2021/01/19/2161036/0/en/Chimerix-Announces-Proposed-75-000-000-Public-Offering-of-Common-Stock.html Chimerix Announces Proposed $75,000,000 Public Offering of Common Stock 2021-01-19T21:19:01Z 2021-02-05T07:57:26Z DURHAM, N.C., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Chimerix, Inc.?(Nasdaq: CMRX), a biopharmaceutical company focused on accelerating the development of medicines to treat cancer and other serious diseases, announced today that it intends to offer and sell, subject to market and other conditions, up to $75,000,000 of shares of its common stock in an underwritten public offering. In addition, Chimerix expects to grant the underwriters a?30-day?option to purchase up to an additional $11,250,000 of shares of common stock. All of the shares to be sold in the offering are to be sold by Chimerix. There can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering.

]]>
2161036 en GlobeNewswire Inc. Chimerix, Inc. Tue, 19 Jan 2021 21:19 GMT Insider's Buy/Sell Stock Market News Prospectus/Announcement of Prospectus
亚洲精品私拍国产在线播放_亚洲综合区图片小说区_亚洲日本欧美日韩高观看